Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis

<p dir="ltr">Meningiomas are the most prevalent primary intracranial tumors. The majority are benign but can undergo dedifferentiation into advanced grades classified by World Health Organization (WHO) into Grades 1 to 3. Meningiomas’ tremendous variability in tumor behavior and slow...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Reem Halabi (22482097) (author)
مؤلفون آخرون:	Fatima Dakroub (13014998) (author), Mohammad Z. Haider (5429717) (author), Stuti Patel (3899836) (author), Nayef A. Amhaz (22482098) (author), Mohammad A. Reslan (22482102) (author), Ali H. Eid (5461829) (author), Yehia Mechref (17849097) (author), Nadine Darwiche (12223496) (author), Firas Kobeissy (17849094) (author), Ibrahim Omeis (11496641) (author), Abdullah Shaito (20545181) (author)
منشور في:	2023
الموضوعات:	Biological sciences Biochemistry and cell biology Genetics Biomedical and clinical sciences Medical biochemistry and metabolomics Neurosciences Oncology and carcinogenesis meningioma NF2 mutations biomarker miRNA proteomics
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis

مواد مشابهة